A Phase I Study of IBI325 in Patients With Advanced Solid Tumor
Clinical trial NCT05246995 · UNKNOWN
Trial details
- NCT number
- NCT05246995
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2023-03-23
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.